Abstract: Methods, devices and systems are disclosed for inter-app communications between software applications on a mobile communications device. In one aspect, a computer-readable medium on a mobile computing device comprising an inter-application communication data structure to facilitate transitioning and distributing data between software applications in a shared app group for an operating system of the mobile computing device includes a scheme field of the data structure providing a scheme id associated with a target software app to transition to from a source software app, wherein the scheme id is listed on a scheme list stored with the source software app; and a payload field of the data structure providing data and/or an identification where to access data in a shared file system accessible to the software applications in the shared app group, wherein the payload field is encrypted.

Abstract: Methods, devices and systems are disclosed for inter-app communications between software applications on a mobile communications device. In one aspect, a computer-readable medium on a mobile computing device comprising an inter-application communication data structure to facilitate transitioning and distributing data between software applications in a shared app group for an operating system of the mobile computing device includes a scheme field of the data structure providing a scheme id associated with a target software app to transition to from a source software app, wherein the scheme id is listed on a scheme list stored with the source software app; and a payload field of the data structure providing data and/or an identification where to access data in a shared file system accessible to the software applications in the shared app group, wherein the payload field is encrypted.

Abstract: An apparatus and method for medical imaging uses a first and second contrast agent, the second agent targeted to a particular tissue type. First images are obtained using the first agent, and second images using the second agent using medical imaging systems. An image processing system is adapted to process the first and second medical images by fitting parameters of a pharmacokinetic model to the first medical images, identifying a nontargeted tissue type, scaling the fitted parameters to best match the nontargeted tissue in the second medical images, executing the pharmacokinetic model to prepare a correction image, and generating corrected medical images by subtracting the correction image from the second medical images.

Abstract: A system for dehydration of organic material comprises a housing structure having an interior chamber, a supply duct, a dual trunk structure, a dry air intake, a central recirculation duct, and a plurality of side recirculation ducts. The side recirculation ducts each have a return plenum extending downward from a top recirculation duct and are configured to recirculate interior air contained in the chamber. The interior air enters the side recirculation ducts through the return plenums and is pushed upward and outward through the top recirculation ducts and back into the interior chamber. The interior chamber has a plurality of exhaust vents positioned in the upper region of its walls. A plurality of portable platforms positioned inside the interior chamber are configured to hold the organic material. The floor of the housing structure can include a plurality of tracks for loading, unloading and positioning the portable platforms.

Abstract: The present disclosure relates to beverage container (10) that includes a lower vessel (12) having a lower vessel neck (16), an upper vessel (22) that is attached to the lower vessel neck (16) and is sized and shaped to hold a liquid therein, a removable cap (40) that is attached to the upper vessel (22), a vessel seal (42) that serves as a liquid- tight barrier between the interior of the upper vessel (22) and the interior of the lower vessel (12), and a tether (44) attached to the vessel seal (42) at one end and the removable cap (40) at the other end. When the removable cap (40) is twisted or removed, it pulls on the tether (44), which pulls and releases the vessel seal (42), thereby allowing liquid from inside the upper vessel (22) to enter the interior of the lower vessel (12).

Abstract: The present dosure relates to beverage container (10) that includes a lower vessel (12) having a lower vessel neck (16), an upper vessel (22) that is attached to the lower vessel neck (16) and is sized and shaped to hold a liquid therein, a removable cap (40) that is attached to the upper vessel (22), a vessel seal (42) that serves as a liquid- tight barrier between the interior of the upper vessel (22) and the interior of the lower vessel (12), and a tether (44) attached to the vessel seal (42) at one end and the removable cap (40) at the other end. When the removable cap (40) is twisted or removed, it pulls on the tether (44), which pulls and releases the vessel seal (42), thereby allowing liquid from inside the upper vessel (22) to enter the interior of the lower vessel (12).

Abstract: A direct digital synthesizer for generating an output signal within a frequency band. The direct digital synthesizer comprises an input section for receiving a phase differential value and generating a phase angle value. A phase-amplitude converter generates an amplitude value in response to the phase angle value. A band-shaped dither generator generates a dither value. A first combiner sums the amplitude value and the dither value to define a first combined value. A second combiner differences the amplitude value and the dither value to define a second combined value. A first digital-to-analog converter (DAC) converts the first combined value to a first analog signal. A second digital-to-analog converter (DAC) converts the second combined value to a second analog signal. An output combiner combines the first analog signal and the second analog signal to generate the output signal.

Abstract: The invention provides a store and forward type electronic consult record with sufficient information for a dermatological specialist or consultant to render a diagnosis and to electronically submit that diagnosis back to the referring provider either in real time or at a later time. Accordingly, the invention provides a series of user interfaces or templates for collecting data from referring provider relating to the patient and the patient's condition. The information is then assembled into a dermatological consult record that may be stored and/or transmitted to a remote computer where it may be accessed by a consulting provider. The consulting provider may access the dermatological consult record at any time, review the record, add a diagnosis and/or treatment recommendation to the record, store the record and electronically transmit the record back to the referring provider. The referring provider may then administer treatment to the patient as recommended.

Abstract: A platform for a turbofan gas turbine engine that does not limit the rotation capability of adjacent fan blades in the event one of the fan blades is impacted by a foreign object. The platform includes a structural body portion and an integrally formed flowpath surface portion. The structural body portion has a contour that matches that of the adjacent fan blades. The flowpath surface portion defines a pair of wings that extend laterally beyond the structural body portion. The wings are frangible so as to break off if an adjacent fan blade rotates in response to an ingestion event. The platform is made from a composite material using a resin transfer molding process.

Abstract: Transgenic mice express increased levels of neurotrophin-3 (NT-3) in epithelium when their ancestors are microinjected with the NT-3 gene. The NT-3 growth factor expressing transgenic mice are useful in the study of neurodegenerative disorders of the brain such as Parkinson's syndrome and Alzheimer's disease, of the spinal cord motor neurons such as amyotrophic lateral sclerosis, and for testing drug candidates for the treatment of these diseases.

Abstract: Transgenic mice that express increased levels of nerve growth factor (NGF) in the epidermis and other stratified, keratinized epithelium. The nerve growth factor expressing transgenic mice are useful in the study of neurodegenerative disorders of the brain such as Parkinson's syndrome and Alzheimer's disease and for testing for drug candidates for the treatment of these diseases.